Montgomery Community Media

Novavax, a vaccine development company headquartered in Gaithersburg, has initiated Phase 3 for its COVID-19 vaccine candidate.  It is the fifth candidate to reach Phase 3 in the U.S., after Pfizer, Moderna, AstraZeneca and Janssen. Novavax is looking for volunteers to participate in vaccine trials, particularly those who are part of at-risk populations like Hispanics, […]

AstraZeneca, a multinational pharmaceutical company with a Gaithersburg campus, announced Monday that its COVID-19 vaccine candidate shows a 70% average efficacy rate. The vaccine candidate AZD1222 was administered in two ways. It showed 90% efficacy when it was given as a half dose and followed by a full dose at least one month later, according […]